Vantage Consulting Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-785
Closed -$245K 18
2024
Q2
$245K Sell
785
-84
-10% -$24.7K 0.18% 101
2024
Q1
$247K Sell
869
-1
-0.1% -$293 0.16% 122
2023
Q4
$251K Sell
870
-28
-3% -$7.63K 0.17% 113
2023
Q3
$241K Sell
898
-149
-14% -$37.2K 0.16% 115
2023
Q2
$232K Sell
1,047
-6
-0.6% -$1.39K 0.13% 160
2023
Q1
$255K Buy
1,053
+189
+22% +$46.4K 0.14% 144
2022
Q4
$227K Sell
864
-170
-16% -$45.6K 0.13% 157
2022
Q3
$233K Buy
1,034
+32
+3% +$7.76K 0.14% 147
2022
Q2
$244K Sell
1,002
-2
-0.2% -$490 0.14% 139
2022
Q1
$243K Sell
1,004
-230
-19% -$52.8K 0.09% 157
2021
Q4
$278K Buy
1,234
+95
+8% +$20.1K 0.07% 137
2021
Q3
$242K Buy
1,139
+203
+22% +$46.7K 0.05% 141
2021
Q2
$228K Buy
+936
New +$230K 0.04% 170
2021
Q1
Sell
-319
Closed -$73K 176
2020
Q4
$73K Buy
+319
New +$73.5K 0.01% 291

Other funds holding AMGN

Vantage Consulting Group's AMGN Position: Q3 2024 in Review

Vantage Consulting Group sold out of Amgen (AMGN) in Q3 2024, closing a stake of 785 shares — an estimated $245K sold.

Vantage Consulting Group first reported a position in AMGN in Q4 2020 and held it in 14 quarters. The position peaked at $278K in Q4 2021. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Vantage Consulting Group reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 785 Amgen shares in Q3 2024, an estimated $245K.
  • Vantage Consulting Group first reported a position in Amgen in Q4 2020 and held it in 14 quarters.
  • Vantage Consulting Group's Amgen position peaked at $278K in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.